FDA orders 23andMe to cease PGS sales

26-11-2013

FDA orders 23andMe to cease PGS sales

The US Food and Drug Administration (FDA) has told genetics company 23andMe to stop selling its Personal Genome Service (PGS) product immediately.


fda, 23andme, pgs, genetics, brca

LSIPR